Preview

Gene One Proposal

Better Essays
Open Document
Open Document
1487 Words
Grammar
Grammar
Plagiarism
Plagiarism
Writing
Writing
Score
Score
Gene One Proposal
Gene One Proposal
William Hart
LDR 531
June 16, 2012

Gene One Proposal The fictional company Gene One knows about innovation. After all, its gene technology changed the produce industry with disease-resistant tomatoes and potatoes (University of Phoenix, 2012). Gene One now faces the challenge of moving the innovation needle again, this time in more unfamiliar fields. The company has set a goal of introducing two new breakthrough technologies in the next three years. These new technologies are critical to hitting a target of 40 percent growth during that same time period. One reason Gene One has set such aggressive goals is that it also plans an Initial Public Offering (IPO) at the end of three years to capitalize on market conditions and provide growth capital. However, company senior leadership lacks experience in the IPO process and the organization’s structure is not yet sufficient for a public company. Gene One is facing a difficult period of change. The organization must keep its innovative spirit and new technology focus, while reshaping itself in the mold of a structured public company. Gene One requires planned change that is intentional and goal-oriented (Robbins & Judge, 2011).
Driving Innovation
Even in an organization known for technology innovation, Gene One faces the need for a change in its approach. Technology innovation and research staff members are expressing dissatisfaction with the company’s decision to go public, believing it will lead to greater pressure to produce. Research and technology staff members also are questioning whether Gene One should leverage its knowledge in its existing fields or expand its innovation toward new markets (University of Phoenix, 2012).
Since the actual innovation, research and development process is clearly one in which Gene One has a successful track record, its current innovation challenge may be more of a change management issue. Gene One needs to get research staff out of its comfort



References: Robbins, S. & Judge, T. (2011). Organizational behavior. (14th ed.). Upper Saddle River, NJ.: Pearson/Prentice Hall. University of Phoenix (2012). Gene One scenario. Retrieved on June 14, 2012 from https://ecampus.phoenix.edu/secure/aapd/gbam/xmba520.1/File1.asp Yukl, G. (2010). Leadership in organizations (7th ed.). Upper Saddle River, NJ: Pearson/Prentice Hall. Yunxia, Z. (2008). Effective Signals: How Can Firms Communicate Their Strategic Intent in IPO Communications?. Academy Of Management Perspectives, 22(2), 106-108. doi:10.5465/AMP.2008.32739766

You May Also Find These Documents Helpful

  • Good Essays

    Riordan Manufacturing

    • 549 Words
    • 3 Pages

    An Initial Public Offering (IPO) is the first time a company issues stock to the public. According to Bateman and Snell, “Initial public stock offerings (IPOs) offer a way to raise capital through federally registered and underwritten sales of shares in the company” (2011, pg. 255). There are various advantages to going public. An IPO may raise capital, reduce debt, improve the balance sheet, and enhance net worth. Riordan may be able to pursue unaffordable opportunities and improve credibility with customers. Investors may be attracted to the company now.…

    • 549 Words
    • 3 Pages
    Good Essays
  • Better Essays

    FIN 516 IPO Paper

    • 1324 Words
    • 4 Pages

    An Initial Public Offering (IPO) is when a private company sells its first stock to the public. This is usually done by company’s who are smaller and or “younger” looking to raise capital in order to expand. It can however be done by larger private companies that want to become public. IPO’s can be a risky investment, as the investors do not know how the stock will do on its first day of trading, in addition, there are not much historical data either. In August 2010, Gevo Inc., filed for IPO with the SEC, which went public in January 2011.…

    • 1324 Words
    • 4 Pages
    Better Essays
  • Best Essays

    Cigna V Aetna

    • 3050 Words
    • 13 Pages

    Innovation expert Tom Kelly recently stated "it's not enough to be an innovator anymore. You have to out-innovate the competition." (Kelly, 2006). Interestingly, it would…

    • 3050 Words
    • 13 Pages
    Best Essays
  • Good Essays

    “Don Ruiz, Chief Executive Officer: At age 37, Don became a young entrepreneur when he recruited four colleagues to make his brainchild -- Gene One -- a reality. As CEO and creative force behind Gene One, Don not only brought his extensive technology and industry knowledge to the company, but a significant part of the $2 million dollar start-up investment as well. Now, as a $400 million company, Gene One is positioned to realize growth targets that will make it an industry leader. Don is excited about the company 's…

    • 850 Words
    • 4 Pages
    Good Essays
  • Best Essays

    Ldr 531 Week 5

    • 2421 Words
    • 10 Pages

    University of Phoenix Scenario (2005). Gene One. Retrieved October 24, 2010 from University of Phoenix, Course materials, LDR531 – Organizational Leadership.…

    • 2421 Words
    • 10 Pages
    Best Essays
  • Better Essays

    Ventria needs to overcome the regulatory environment and manage its stakeholder relations in order to succeed and release this product for sale. In order to do so they must establish a strategic plan to improve their triple bottom line performance. They need to convince stakeholders that the potential benefits are desirable and that they can safely and responsibly deliver the product to be commercialized. Even then, Ventria and the biotechnology industry might always face opposition from groups against genetically modified organisms in which human genes are also manipulated.…

    • 1049 Words
    • 5 Pages
    Better Essays
  • Powerful Essays

    Marketing Greggs Plc

    • 10183 Words
    • 41 Pages

    Trott, P. (2011) Innovation management and new product development. 5th edn. [Online]. Essex: Harlow: Financial Times Prentice Hall. Available at: https://www.dawsonera.com. (Accessed: 14 January 2015).…

    • 10183 Words
    • 41 Pages
    Powerful Essays
  • Better Essays

    Jetblue Ipo

    • 1236 Words
    • 5 Pages

    Draho, J. (2004). “The IPO Decision: Why and How Companies Go Public”. Cheltenham, UK: Edward Elgar Publishing.…

    • 1236 Words
    • 5 Pages
    Better Essays
  • Powerful Essays

    Genentech Essay

    • 2177 Words
    • 9 Pages

    Genentech employs best scientist in the world and it encourages them to pursue projects not only associated to the company’s goal, but also to each scientist personal interest.…

    • 2177 Words
    • 9 Pages
    Powerful Essays
  • Satisfactory Essays

    The evidence the CEO is using to suggest that Genex is not using technology competively is that Genex does not get operated towards a single business. But, act as a separate parts. The CEO suggests that the IT department at Genex Fuels brings up with new ideas and innovation. Additionally, he [CEO] researched by getting ahead of the curve that they are. But, the IT could not come up with those ideas with certain lags between the system. Thus, according to the case study, the CEO concludes in a way that the IT should be more flexible and responsive in overcoming the technology lags in order to retain, or stay in competitive.…

    • 240 Words
    • 1 Page
    Satisfactory Essays
  • Powerful Essays

    Gupta. A. K., & Wilemon. D. L. 1990. Accelerating the development of technology-based new products. California Management Review, 32(2):24-44.…

    • 2167 Words
    • 9 Pages
    Powerful Essays
  • Good Essays

    Roche Assignment

    • 701 Words
    • 3 Pages

    Some analyst are concern that Genentech would lose its independence for pursing its own projects, allocate enough amount of money to Research and Development, and its key Scientifics and top management might leave the company.…

    • 701 Words
    • 3 Pages
    Good Essays
  • Better Essays

    Ktm Case Report

    • 2977 Words
    • 12 Pages

    Kelley, J., Burke, R., & Markham, J. (2011). Is Your Company IPO-Ready?. Corporate Finance Review, 15(5), 23-27.…

    • 2977 Words
    • 12 Pages
    Better Essays
  • Good Essays

    Open Innovation

    • 1241 Words
    • 5 Pages

    There now are many famous cases in which companies have developed disruptive technologies but have nonetheless failed to capitalize on them. One reason for failure is that managers often wrongly assume that just because customers are fascinated by an innovation, there also exists a corresponding business model. Henry Chesbrough used the Xerox Palo Alto Research Center (PARC) as an…

    • 1241 Words
    • 5 Pages
    Good Essays
  • Better Essays

    Case Study

    • 1373 Words
    • 5 Pages

    GEN News Highlights. (2012, July 3). Retrieved June 1, 2014, from Genetic Engineering & Biotechnology News: http://www.genengnews.com/gen-news-highlights/three-years-after-merger-genentech-r-d-outshines-that-of-roche-s/81246997/…

    • 1373 Words
    • 5 Pages
    Better Essays